300
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy

ORCID Icon, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ORCID Icon, , , , , , , , , , , , , , ORCID Icon, , , & show all
Pages 313-320 | Received 01 Sep 2021, Accepted 15 Nov 2021, Published online: 27 Dec 2021

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.